Financials data is unavailable for this security.
View more
Year on year Aoxing Pharmaceutical Company Inc had net income fall -62.49% from 5.49m to 2.06m despite a 26.88% increase in revenues from 25.48m to 32.33m. An increase in the selling, general and administrative costs as a percentage of sales from 40.07% to 45.41% was a component in the falling net income despite rising revenues.
Gross margin | 76.19% |
---|---|
Net profit margin | -4.85% |
Operating margin | 3.21% |
Return on assets | -2.41% |
---|---|
Return on equity | -7.20% |
Return on investment | -7.06% |
More ▼
Cash flow in USDView more
In 2016, Aoxing Pharmaceutical Company Inc increased its cash reserves by 28.68%, or 1.54m. Cash Flow from Financing totalled 2.95m or 9.11% of revenues. In addition the company used 534.99k for operations while cash used for investing totalled 117.86k.
Cash flow per share | -0.0062 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2507 |
---|---|
Tangible book value per share | 0.2271 |
More ▼
Balance sheet in USDView more
Current ratio | 0.7915 |
---|---|
Quick ratio | 0.7368 |
Total debt/total equity | 1.45 |
---|---|
Total debt/total capital | 0.6052 |
More ▼